Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112778261B details a mild silver-catalyzed route to isocoumarins, offering cost-effective manufacturing and scalable supply chain solutions.
Patent CN109384789B details a mild Ag(I)-catalyzed route to indoloazepines, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101735095A details a novel copper-catalyzed oxidative coupling for alpha-carbonyl amides, offering significant cost reduction and simplified supply chains for pharmaceutical intermediate manufacturing.
Novel radical cyclization method for benzimidazol[2,1-a]isoquinolin-6(5H)-ones. Efficient route reducing costs in pharmaceutical intermediate manufacturing with high purity.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazole-3-ones offers high yields and broad substrate scope for reliable pharmaceutical intermediate supply chains.
Patent CN111533706A reveals a copper-catalyzed one-pot method for triazines. Achieve cost reduction in fine chemical manufacturing with air-stable catalysts and high atom economy.
Patent CN113121462B reveals a safe, metal-free synthesis for 5-trifluoromethyl-1,2,3-triazoles using diazo compounds, offering significant cost and safety advantages.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Novel palladium-catalyzed reductive aminocarbonylation method for high-purity quinolinone derivatives, offering scalable routes for pharmaceutical intermediates.
Patent CN108503549A enables mild one-pot synthesis of aromatic trifluoroethyl esters. Delivers high purity, cost efficiency, and supply chain reliability for global pharmaceutical intermediates.
Patent CN113880781B reveals glucose-based synthesis for trifluoromethyl triazoles. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable biomass sources.
Patent CN108727244A enables additive-free 2-pyrrolidone synthesis. Offers high purity, cost reduction, and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN107973778B details Ru-catalyzed synthesis for optoelectronic and pharma use. Offers green, scalable production without oxidants for reliable supply chains.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for high-purity pharmaceutical intermediates without heavy metals.
Patent CN116813544B reveals catalyst-free heating method for quinoline. Delivers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Patent CN111675662B reveals a robust FeCl3-catalyzed route for quinazolinones, offering cost-effective manufacturing and scalable supply chain solutions.
Novel iodine-promoted method using DMF as carbon source offers cost-effective, scalable production of high-purity triazole pharmaceutical intermediates.
Patent CN105085208B reveals mild Pd-catalyzed benzofluorenone synthesis. Offers cost reduction and supply reliability for fine chemical intermediates.
Patent CN108558692B reveals a mild NHC-catalyzed route for amide synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.